Quality of life in men with arterial hypertension
e202109110
Keywords:
Calidad de vida, Hipertensión, Síntomas prostáticos del tracto urinario inferiorAbstract
Background: Systemic arterial hypertension is a Public Health problem, being the most important modifiable risk factor for morbidity and mortality, and the main single contributor to death and disability from all causes. Our objective was to estimate health-related quality of life using the MINICHAL questionnaire, to identify the problems with the greatest impact and the associated risk factors.
Methods: An observational prevalence study of a sample of 262 hypertensive men was carried out. Sociodemographic variables, comorbidity, degree of control and treatment, cardiovascular risk, clinical data and target organ lesions were collected. The following questionnaires were applied: MINICHAL, International Score of Prostate Symptoms and International Index of Erectile Function. Quantitative variables are expressed as mean (standard deviation) and median. The qualitative variables are expressed as absolute value and percentage with the estimation of its 95% confidence interval. The comparison of means was carried out by means of the Student’s T test or the Mann Whitney test, as appropriate after checking the normality of the variables with the Kolmogorov-Smirnov test. The association between qualitative variables was estimated using the Chi square statistic or Fisher’s exact test. To determine variables that are associated or not with the presence of worse quality of life, multivariate logistic regression was performed, adjusting for those variables that were significant in the univariate analysis or clinically relevant.
Results: Of the 262 hypertensive men included in the study, 4.6% declared that neither hypertension nor treatment affected their quality of life. Only 58% compared 52.7% presented a good quality of life through the domains “mental state” with respect to “somatic manifestations” of the MINICHAL questionnaire, with prostate symptoms being the one that had a considerable negative impact on both domains.The multivariate logistic regression analysis showed that the sum of the antihypertensive medication and the moderate-severe degree of prostatic symptoms had an independent effect to predict worse quality of life in the “mental state” domain, while the sum of concomitant medication, HDL-cholesterol levels, a pathological electrocardiogram and filling symptoms had an effect on the domain “somatic manifestations”.
Conclusions: When analyzing the “mental state” and the “somatic manifestations” of the MINICHAL questionnaire, only half of them presented a good quality of life.
Downloads
References
Oparil S, Acelajado MC, Bakris GL et al. Hypertension. Nat Rev Dis Primers. Mar 22 2018;4:18014. doi: 10.1038/nrdp.2018.14
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. Nov 10 2018;392(10159):1923-1994. doi: 10.1016/s0140-6736(18)32225-6
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. Jan 7 2017;389(10064):37-55. doi: 10.1016/s0140-6736(16)31919-5
Rosendorff C, Lackland DT, Allison M et al. Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. Circulation. May 12 2015;131(19):e435-70. doi: 10.1161/cir.0000000000000207
Brotons Cuixart C, Alemán Sánchez JJ, Banegas Banegas JR et al. Recomendaciones preventivas cardiovasculares. Actualizaciones PAPPS 2018. Aten Primaria. May 2018;50 Suppl 1(Suppl 1):4-28. Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2018. doi: 10.1016/s0212-6567(18)30360-3
James PA, Oparil S, Carter BL et al. 2014 evidence-based guideline for the management of high blood
pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). Jama. Feb 5 2014;311(5):507-20. doi: 10.1001/jama.2013.284427
Menendez E, Delgado E, Fernandez-Vega F et al. Prevalence, Diagnosis, Treatment, and Control of Hypertension in Spain. Results of the Di@bet.es Study. Rev Esp Cardiol (Engl Ed). Jun 2016;69(6):572-8. doi: 10.1016/j.rec.2015.11.034. Epub 2016 Mar 12.
Unger T, Borghi C, Charchar F et al. 2020 International Society of Hypertension global hypertension practice guidelines. J Hypertens. Jun 2020;38(6):982-1004. doi: 10.1097/hjh.0000000000002453
Williams B, Mancia G, Spiering W et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. Oct 2018;36(10):1953-2041. doi: 10.1097/hjh.0000000000001940
Trevisol DJ, Moreira LB, Kerkhoff A, Fuchs SC, Fuchs FD. Health-related quality of life and hypertension: a systematic review and meta-analysis of observational studies. J Hypertens. Feb 2011;29(2):179-88. doi: 10.1097/HJH.0b013e328340d76f
Organization WH. Preamble to the Constitution of WHO. https://www.who.int/about/who-we-are/constitutionhttps://www.who.int/about/who-we-are/constitution; 1946 [consultada el 21 de agosto de 2020].
Carvalho MA, Silva IB, Ramos SB, Coelho LF, Goncalves ID, Figueiredo Neto JA. Quality of life of hypertensive patients and comparison of two instruments of HRQOL measure. Comparative Study. Arq Bras Cardiol. May 2012;98(5):442-51. Epub 2012 Apr 5.
Banegas JR, Guallar-Castillón P, Rodríguez-Artalejo F, Graciani A, López-García E, Ruilope LM. Association between awareness, treatment, and control of hypertension, and quality of life among older adults in Spain. Am J Hypertens. Jul 2006;19(7):686-93. doi: 10.1016/j.amjhyper.2006.01.015
Haynes RB, Sackett DL, Taylor DW, Gibson ES, Johnson AL. Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med. Oct 5 1978;299(14):741-4. doi: 10.1056/nejm197810052991403
Alderman MH, Charlson ME, Melcher LA. Labelling and absenteeism: the Massachusetts Mutual experience. Clin Invest Med. 1981;4(3-4):165-171.
Pickering TG. Now we are sick: labeling and hypertension. J Clin Hypertens (Greenwich). Jan 2006;8(1):57-60. doi: 10.1111/j.1524-6175.2005.05121.x
Carris NW, Smith SM. Quality of Life in Treatment-Resistant Hypertension. Curr Hypertens Rep. Aug 2015;17(8):61. doi: 10.1007/s11906-015-0578-5
Ito H, Yoshiyasu T, Yamaguchi O, Yokoyama O. Male Lower Urinary Tract Symptoms: Hypertension as a Risk Factor for Storage Symptoms, but Not Voiding Symptoms. Low Urin Tract Symptoms. May 2012;4(2):68-72. doi: 10.1111/j.1757-5672.2011.00115.x
Choi WS, Heo NJ, Lee YJ, Son H. Factors that influence lower urinary tract symptom (LUTS)-related quality of life (QoL) in a healthy population. World J Urol. Nov 2017;35(11):1783-1789. doi: 10.1007/s00345-017-2052-2. Epub 2017 Jun 5.
Rogan A, McCarthy K, McGregor G et al. Quality of life measures predict cardiovascular health and physical performance in chronic renal failure patients. PLoS One. 2017;12(9):e0183926. doi: 10.1371/journal.pone.0183926
Wiklund I, Halling K, Rydén-Bergsten T, Fletcher A. Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal Treatment (HOT) study. Blood Press. Nov 1997;6(6):357-64. doi: 10.3109/08037059709062095
Ko HY, Lee JK, Shin JY, Jo E. Health-Related Quality of Life and Cardiovascular Disease Risk in Korean Adults. Korean J Fam Med. Nov 2015;36(6):349-56. doi: 10.4082/kjfm.2015.36.6.349. Epub 2015 Nov 20.
Li C, Ford ES, Mokdad AH, Balluz LS, Brown DW, Giles WH. Clustering of cardiovascular disease risk factors and health-related quality of life among US adults. Value Health. Jul-Aug 2008;11(4):689-99. doi: 10.1111/j.1524-4733.2007.00307.x. Epub 2008 Jan 8.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Mónica Diosdado Figueiredo
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
